Chemspec International Limited Announces Management Appointments
24 7월 2009 - 6:00PM
PR Newswire (US)
SHANGHAI, July 24 /PRNewswire-Asia-FirstCall/ -- Chemspec
International Limited (NYSE:CPC) ("Chemspec" or the "Company"), a
leading China-based contract manufacturer of highly-engineered
specialty chemicals, today announced two recent senior management
appointments: Dr. Jinhua (Jim) Chen was promoted to the vice
president of process research and development, and Dr. Yuelie Lu
was appointed as the vice president of pharmaceutical business
development. Previously the director of research and development at
Chemspec, Dr. Chen will continue to oversee process research and
development at Chemspec. Prior to joining Chemspec in June 2008,
Dr. Chen was an associate research investigator in the global
pharmaceutical research and development division at Abbott
Laboratories in Chicago, Illinois. Dr. Chen was also an American
Chemical Society Industrial Innovation Award winner and a member of
the teams at Abbott Laboratories which launched the drugs Ritonavir
and Lopinavir. He holds a Ph.D. in organometallic chemistry from
the University of New Brunswick in Canada and a B.S. in organic
chemistry from Xiamen University in the People's Republic of China.
Dr. Lu was recently hired as the vice president of pharmaceutical
business development to oversee the expansion of our business
related to pharmaceutical chemicals and the operation of our
certified good manufacturing practices ("cGMP") facilities. Prior
to joining Chemspec, Dr. Lu held a broad range of responsibilities
at multiple pharmaceutical companies in the United States, with his
two most recent positions being an associate director of chemical
development at Lexicon Pharmaceuticals in New Jersey and a
principle scientist at Amgen Inc. in California. Dr. Lu holds a
Ph.D. from Purdue University and a B.S. from the University of
Science & Technology of China. "Dr. Chen and Dr. Lu both bring
additional knowledge and operational expertise to our management
team," commented Dr. Jianhua Yang, chairman and CEO of Chemspec.
"Dr. Chen has 12 years of experience in cGMP manufacturing. Over
the past year at Chemspec, Dr. Chen has led the process research
and development team to provide high-quality, efficient and
environmentally-friendly services to our customers. Dr. Lu brings
us his extensive experience in contract manufacturing project
management and cGMP regulation compliance that will facilitate the
expansion of our business related to pharmaceutical chemicals."
Safe Harbor Statements This announcement contains forward-looking
statements. These statements constitute "forward-looking"
statements within the meaning of Section 27A of the Securities Act
of 1933, as amended, and Section 21E of the Securities Exchange Act
of 1934, as amended, and as defined in the U.S. Private Securities
Litigation Reform Act of 1995. These forward-looking statements can
be identified by terminology such as "will," "expects,"
"anticipates," "future," "intends," "plans," "believes,"
"estimates" and similar statements. Such statements involve certain
risks and uncertainties that could cause actual results to differ
materially from those in the forward-looking statements. Further
information regarding these and other risks is included in
Chemspec's filings with the U.S. Securities and Exchange
Commission, including its registration statement on Form F-1, as
amended from time to time. Chemspec does not undertake any
obligation to update any forward-looking statement, except as
required under applicable law. About Chemspec Chemspec is a leading
China-based contract manufacturer of highly engineered specialty
chemicals and the largest manufacturer of fluorinated specialty
chemicals in China based on sales. In manufacturing specialty
chemicals, Chemspec also provides process design and process
development services, which enable efficient and rapid production
of specialty chemicals that are incorporated into the products of
Chemspec's end users. Chemspec's customers and end users include
electronics, pharmaceutical and agrochemical companies. For more
information, please visit http://www.chemspec.com.cn/ . For further
information, please contact: Chemspec International Ltd. In
Shanghai Bing Zhu Chief Financial Officer Tel: +86-21-5270-2636
x8053 Email: Christensen In New York Kathy Li Tel: +1-212-618-1978
Email: In Hong Kong Tip Fleming Tel: +852-9212-0684 Email:
DATASOURCE: Chemspec International Limited CONTACT: Chemspec
International Ltd.: In Shanghai: Bing Zhu, Chief Financial Officer
at +86-21-5270-2636 x8053 or ; Or Christensen: In New York: Kathy
Li at +1-212-618-1978 or ; In Hong Kong: Tip Fleming at
+852-9212-0684 or Web site: http://www.chemspec.com.cn/
Copyright